James H. Tabibian

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

Christopher L. Bowlus, Lionel Arrivé, Annika Bergquist et al. · Hepatology · 2022 · 370 citations

Medicine, Pathology, Radiology +17

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis ‐ a pilot study

James H. Tabibian, Emma Weeding, Roberta A. Jorgensen et al. · Alimentary Pharmacology & Therapeutics · 2013 · 267 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis

James H. Tabibian, Steven P. O’Hara, Patrick L. Splinter et al. · Hepatology · 2014 · 247 citations · Full text

Medicine, Pathobiology, Pathology +16

Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis

James H. Tabibian, Steven P. O’Hara, Christy E. Trussoni et al. · Hepatology · 2015 · 219 citations · Full text

Medicine, Pathobiology, Pathology +17

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors

Anilga Moradkhani, Linda J. Beckman, James H. Tabibian · Journal of Crohn s and Colitis · 2012 · 154 citations

Medicine, Clinical Sciences, Gastroenterology +11